SINOPHARM GRP CO. H YC 1 earnings per share and revenue

X2S earnings per share for the last semiannual are 0.15 EUR whereas the estimation was 0.18 EUR which accounts for -13.77% surprise. Company revenue for the same period amounts to 37.85 B EUR despite the estimated figure of 40.02 B EUR. Estimated earnings per share for the next semiannual are 0.19 EUR, and revenue is expected to reach 40.48 B EUR. Also watch annual changes over time to get a bigger picture of X2S earnings per share and revenue dynamics.